Dermata Therapeutics Stock Volatility
| DRMA Stock | USD 1.08 0.04 3.57% |
Dermata Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0719, which denotes the company had a -0.0719% return per unit of risk over the last 3 months. Dermata Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dermata Therapeutics' Mean Deviation of 5.17, standard deviation of 8.41, and Variance of 70.73 to check the risk estimate we provide. Key indicators related to Dermata Therapeutics' volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Dermata Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Dermata daily returns, and it is calculated using variance and standard deviation. We also use Dermata's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Dermata Therapeutics volatility.
Dermata |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Dermata Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Dermata Therapeutics at lower prices to lower their average cost per share. Similarly, when the prices of Dermata Therapeutics' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving together with Dermata Stock
| 0.68 | VALN | Valneva SE ADR | PairCorr |
| 0.67 | ERNA | Eterna Therapeutics | PairCorr |
| 0.66 | AZN | AstraZeneca PLC ADR | PairCorr |
Moving against Dermata Stock
| 0.73 | BMY | Bristol Myers Squibb | PairCorr |
| 0.57 | ESPR | Esperion Therapeutics | PairCorr |
| 0.49 | FLGC | Flora Growth Corp | PairCorr |
Dermata Therapeutics Market Sensitivity And Downside Risk
Dermata Therapeutics' beta coefficient measures the volatility of Dermata stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Dermata stock's returns against your selected market. In other words, Dermata Therapeutics's beta of 1.87 provides an investor with an approximation of how much risk Dermata Therapeutics stock can potentially add to one of your existing portfolios. Dermata Therapeutics is displaying above-average volatility over the selected time horizon. Dermata Therapeutics is a potential penny stock. Although Dermata Therapeutics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Dermata Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Dermata instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Dermata Therapeutics Demand TrendCheck current 90 days Dermata Therapeutics correlation with market (Dow Jones Industrial)Dermata Beta |
Dermata standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 8.47 |
It is essential to understand the difference between upside risk (as represented by Dermata Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Dermata Therapeutics' daily returns or price. Since the actual investment returns on holding a position in dermata stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Dermata Therapeutics.
Dermata Therapeutics Stock Volatility Analysis
Volatility refers to the frequency at which Dermata Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Dermata Therapeutics' price changes. Investors will then calculate the volatility of Dermata Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Dermata Therapeutics' volatility:
Historical Volatility
This type of stock volatility measures Dermata Therapeutics' fluctuations based on previous trends. It's commonly used to predict Dermata Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Dermata Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Dermata Therapeutics' to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Dermata Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Dermata Therapeutics Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 1.8702 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Dermata Therapeutics will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Dermata Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Dermata Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Dermata stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Dermata Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a Dermata Therapeutics Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Dermata Therapeutics Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Dermata Therapeutics is -1390.19. The daily returns are distributed with a variance of 71.79 and standard deviation of 8.47. The mean deviation of Dermata Therapeutics is currently at 5.11. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.75
α | Alpha over Dow Jones | -0.77 | |
β | Beta against Dow Jones | 1.87 | |
σ | Overall volatility | 8.47 | |
Ir | Information ratio | -0.08 |
Dermata Therapeutics Stock Return Volatility
Dermata Therapeutics historical daily return volatility represents how much of Dermata Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 8.4726% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7694% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Dermata Therapeutics Volatility
Volatility is a rate at which the price of Dermata Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Dermata Therapeutics may increase or decrease. In other words, similar to Dermata's beta indicator, it measures the risk of Dermata Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of Dermata Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Selling And Marketing Expenses | 3.6 B | 3.2 B | |
| Market Cap | 78 M | 74.1 M |
Dermata Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Dermata Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Dermata Therapeutics' price varies over time.
3 ways to utilize Dermata Therapeutics' volatility to invest better
Higher Dermata Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Dermata Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Dermata Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Dermata Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Dermata Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Dermata Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Dermata Therapeutics Investment Opportunity
Dermata Therapeutics has a volatility of 8.47 and is 11.0 times more volatile than Dow Jones Industrial. 75 percent of all equities and portfolios are less risky than Dermata Therapeutics. You can use Dermata Therapeutics to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Dermata Therapeutics to be traded at $1.0368 in 90 days.Average diversification
The correlation between Dermata Therapeutics and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Dermata Therapeutics Additional Risk Indicators
The analysis of Dermata Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Dermata Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of Dermata Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.31) | |||
| Mean Deviation | 5.17 | |||
| Coefficient Of Variation | (1,434) | |||
| Standard Deviation | 8.41 | |||
| Variance | 70.73 | |||
| Information Ratio | (0.08) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Dermata Therapeutics Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Dermata Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Dermata Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Dermata Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Dermata Therapeutics.
Complementary Tools for Dermata Stock analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |